
Eric Olson
Examiner (ID: 3855, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1693, 1673 |
| Total Applications | 1706 |
| Issued Applications | 961 |
| Pending Applications | 123 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7426671
[patent_doc_number] => 20040229826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Dose-dense & sequential adjuvant cancer chemotherapy'
[patent_app_type] => new
[patent_app_number] => 10/735180
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7143
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735180
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735180 | Dose-dense & sequential adjuvant cancer chemotherapy | Dec 11, 2003 | Abandoned |
Array
(
[id] => 7310886
[patent_doc_number] => 20040143014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Therapeutic use of alpha-2-delta ligands'
[patent_app_type] => new
[patent_app_number] => 10/735398
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11333
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143014.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735398 | Therapeutic use of alpha-2-delta ligands | Dec 11, 2003 | Abandoned |
Array
(
[id] => 7447941
[patent_doc_number] => 20040186120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Method of treating movement disorders using barbituric acid derivatives'
[patent_app_type] => new
[patent_app_number] => 10/735514
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10385
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186120.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735514 | Method of treating movement disorders using barbituric acid derivatives | Dec 10, 2003 | Issued |
Array
(
[id] => 1077029
[patent_doc_number] => 07615542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV'
[patent_app_type] => utility
[patent_app_number] => 10/530088
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6509
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615542.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530088 | Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV | Dec 7, 2003 | Issued |
Array
(
[id] => 7142904
[patent_doc_number] => 20050118234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Methods and kits related to administration of a fructooligosaccharide'
[patent_app_type] => utility
[patent_app_number] => 10/724839
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4711
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10724839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/724839 | Methods and kits related to administration of a fructooligosaccharide | Nov 30, 2003 | Abandoned |
Array
(
[id] => 885161
[patent_doc_number] => 07351863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-01
[patent_title] => 'Method of fluorination'
[patent_app_type] => utility
[patent_app_number] => 10/537437
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10989
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/351/07351863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537437
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537437 | Method of fluorination | Nov 30, 2003 | Issued |
Array
(
[id] => 5656515
[patent_doc_number] => 20060142251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Anti-microbial agents derived from methionine sulfoximine analogues'
[patent_app_type] => utility
[patent_app_number] => 10/534660
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9973
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534660 | Anti-microbial agents derived from methionine sulfoximine analogues | Nov 16, 2003 | Abandoned |
Array
(
[id] => 7468384
[patent_doc_number] => 20040096413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Cosmetic composition comprising a complex of cyclodextrin and vitamin F'
[patent_app_type] => new
[patent_app_number] => 10/712703
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4283
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096413.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712703
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712703 | Cosmetic composition comprising a complex of cyclodextrin and vitamin F | Nov 11, 2003 | Issued |
Array
(
[id] => 7286939
[patent_doc_number] => 20040146941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Chemical encoding technology for combinatorial synthesis'
[patent_app_type] => new
[patent_app_number] => 10/698932
[patent_app_country] => US
[patent_app_date] => 2003-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10103
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146941.pdf
[firstpage_image] =>[orig_patent_app_number] => 10698932
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/698932 | Chemical encoding technology for combinatorial synthesis | Nov 2, 2003 | Abandoned |
Array
(
[id] => 7207077
[patent_doc_number] => 20040087558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain'
[patent_app_type] => new
[patent_app_number] => 10/693722
[patent_app_country] => US
[patent_app_date] => 2003-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22117
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087558.pdf
[firstpage_image] =>[orig_patent_app_number] => 10693722
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/693722 | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | Oct 22, 2003 | Abandoned |
Array
(
[id] => 7173092
[patent_doc_number] => 20050203142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain'
[patent_app_type] => utility
[patent_app_number] => 10/693794
[patent_app_country] => US
[patent_app_date] => 2003-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19151
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203142.pdf
[firstpage_image] =>[orig_patent_app_number] => 10693794
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/693794 | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | Oct 22, 2003 | Abandoned |
Array
(
[id] => 7208112
[patent_doc_number] => 20040087658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/691895
[patent_app_country] => US
[patent_app_date] => 2003-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34115
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087658.pdf
[firstpage_image] =>[orig_patent_app_number] => 10691895
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/691895 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | Oct 22, 2003 | Abandoned |
Array
(
[id] => 7168978
[patent_doc_number] => 20040077562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Combination drug'
[patent_app_type] => new
[patent_app_number] => 10/416837
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3964
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077562.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416837
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416837 | Combination drug | Oct 19, 2003 | Abandoned |
Array
(
[id] => 7224871
[patent_doc_number] => 20040072798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Compositions comprising cyclodextrins and no-releasing drugs'
[patent_app_type] => new
[patent_app_number] => 10/450847
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5517
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450847 | Compositions comprising cyclodextrins and no-releasing drugs | Oct 14, 2003 | Abandoned |
Array
(
[id] => 7281284
[patent_doc_number] => 20040063661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Treatment of statin side effects'
[patent_app_type] => new
[patent_app_number] => 10/433074
[patent_app_country] => US
[patent_app_date] => 2003-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6903
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063661.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433074
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433074 | Treatment of statin side effects | Oct 7, 2003 | Abandoned |
Array
(
[id] => 7474395
[patent_doc_number] => 20040122044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations'
[patent_app_type] => new
[patent_app_number] => 10/677960
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7451
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10677960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/677960 | Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations | Oct 2, 2003 | Abandoned |
Array
(
[id] => 7455431
[patent_doc_number] => 20040068108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => ' Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them'
[patent_app_type] => new
[patent_app_number] => 10/677894
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13760
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20040068108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10677894
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/677894 | Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them | Oct 1, 2003 | Issued |
Array
(
[id] => 7474472
[patent_doc_number] => 20040122059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'PPAR-gamma ligands in the treatment of asthma and allergies'
[patent_app_type] => new
[patent_app_number] => 10/674395
[patent_app_country] => US
[patent_app_date] => 2003-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13394
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10674395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/674395 | PPAR-gamma ligands in the treatment of asthma and allergies | Sep 30, 2003 | Abandoned |
Array
(
[id] => 5875209
[patent_doc_number] => 20060166907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Composition for the treatment of nasopharyngeal carcinoma and method of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/529431
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13628
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529431 | Composition for the treatment of nasopharyngeal carcinoma and method of use thereof | Sep 28, 2003 | Abandoned |
Array
(
[id] => 7674682
[patent_doc_number] => 20040127436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => '1,3,5-Triazines for treatment of viral diseases'
[patent_app_type] => new
[patent_app_number] => 10/670915
[patent_app_country] => US
[patent_app_date] => 2003-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32824
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10670915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/670915 | 1,3,5-triazines for treatment of viral diseases | Sep 23, 2003 | Issued |